Careray Digital Medical Technology Co (SHSE:688607) Beneish M-Score: -2.29 (As of Jun. 28, 2026)


SHSE:688607 Careray Digital Medical Technology Co Ltd SHSE:688607
65 GF Score
Price ¥46.70
GF Value ¥29.46
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Careray Digital Medical Technology Co Beneish M-Score?

Careray Digital Medical Technology Co SHSE:688607 -3.51% 65 Beneish M-Score is -2.29 as of Jun. 28, 2026. GuruFocus rates SHSE:688607 with a GF Score™ of 65/100 and a GF Value™ of ¥29.46 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 766 Medical Devices & Instruments companies, Careray Digital Medical Technology Co ranks worse than 70.63% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.29 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Careray Digital Medical Technology Co's Beneish M-Score or its related term are showing as below:

SHSE:688607' s Beneish M-Score Range Over the Past 10 Years
Min: -2.51   Med: -2.06   Max: -0.95
Current: -2.29

During the past 9 years, the highest Beneish M-Score of Careray Digital Medical Technology Co was -0.95. The lowest was -2.51. And the median was -2.06.


Careray Digital Medical Technology Co Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Careray Digital Medical Technology Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Careray Digital Medical Technology Co Beneish M-Score Chart

Careray Digital Medical Technology Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only -2.06 -2.45 -2.21 -1.31 -2.06

Careray Digital Medical Technology Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.95 -2.05 -1.73 -2.06 -2.29

SHSE:688607 vs ABT, SYK, MDT: Beneish M-Score Comparison

For the Medical Devices subindustry, Careray Digital Medical Technology Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Careray Digital Medical Technology Co Beneish M-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Careray Digital Medical Technology Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Careray Digital Medical Technology Co's Beneish M-Score falls into.


SHSE:688607
65GF Score
Careray Digital Medical Technology Co Ltd SHSE:688607
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Careray Digital Medical Technology Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Careray Digital Medical Technology Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9851+0.528 * 1.0533+0.404 * 1.2594+0.892 * 1.0902+0.115 * 1
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.2159+4.679 * 0.036622-0.327 * 1.4396
=-2.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was ¥118.3 Mil.
Revenue was 68.538 + 94.839 + 81.137 + 86.444 = ¥331.0 Mil.
Gross Profit was 24.327 + 31.601 + 29.604 + 35.384 = ¥120.9 Mil.
Total Current Assets was ¥516.5 Mil.
Total Assets was ¥961.7 Mil.
Property, Plant and Equipment(Net PPE) was ¥230.7 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0.0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥29.3 Mil.
Total Current Liabilities was ¥110.8 Mil.
Long-Term Debt & Capital Lease Obligation was ¥6.9 Mil.
Net Income was -16.205 + -7.015 + 1.087 + 2.542 = ¥-19.6 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ¥0.0 Mil.
Cash Flow from Operations was -16.826 + 0.983 + -24.246 + -14.72 = ¥-54.8 Mil.
Total Receivables was ¥110.1 Mil.
Revenue was 58.439 + 102.599 + 66.617 + 75.915 = ¥303.6 Mil.
Gross Profit was 20.973 + 33.954 + 31.062 + 30.836 = ¥116.8 Mil.
Total Current Assets was ¥581.5 Mil.
Total Assets was ¥946.1 Mil.
Property, Plant and Equipment(Net PPE) was ¥197.1 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0.0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥22.1 Mil.
Total Current Liabilities was ¥71.1 Mil.
Long-Term Debt & Capital Lease Obligation was ¥9.4 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(118.258 / 330.958) / (110.114 / 303.57)
=0.35732 / 0.36273
=0.9851

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(116.825 / 303.57) / (120.916 / 330.958)
=0.384837 / 0.365351
=1.0533

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (516.533 + 230.662) / 961.663) / (1 - (581.465 + 197.085) / 946.079)
=0.223018 / 0.177077
=1.2594

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=330.958 / 303.57
=1.0902

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0 / (0 + 197.085)) / (0 / (0 + 230.662))
=0 / 0
=1

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(29.254 / 330.958) / (22.069 / 303.57)
=0.088392 / 0.072698
=1.2159

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((6.931 + 110.816) / 961.663) / ((9.389 + 71.08) / 946.079)
=0.122441 / 0.085055
=1.4396

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-19.591 - 0 - -54.809) / 961.663
=0.036622

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Careray Digital Medical Technology Co has a M-score of -2.29 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.29 mean?
Careray Digital Medical Technology Co (SHSE:688607) has a Beneish M-Score of -2.29 as of Jun. 28, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Careray Digital Medical Technology Co and its competitors. According to the industry distribution chart, Careray Digital Medical Technology Co ranks #541 out of 766 companies in the Medical Devices & Instruments industry, placing it in the top 70.6%.
Is Careray Digital Medical Technology Co's Beneish M-Score too high?
Careray Digital Medical Technology Co's current Beneish M-Score is -2.29. Based on the distribution chart, Careray Digital Medical Technology Co ranks #541 out of 766 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Careray Digital Medical Technology Co has a GF Score™ of 65/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Careray Digital Medical Technology Co's Beneish M-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Careray Digital Medical Technology Co ranks #541 out of 766 companies for Beneish M-Score. This places Careray Digital Medical Technology Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Devices & Instruments company?
A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Careray Digital Medical Technology Co and its competitors. Careray Digital Medical Technology Co's current Beneish M-Score is -2.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Careray Digital Medical Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Careray Digital Medical Technology Co (SHSE:688607) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥29.46, compared to a current price of ¥46.70 — trading 58.5% above its estimated fair value. The current Beneish M-Score is -2.29. Careray Digital Medical Technology Co's overall GF Score™ is 65/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Careray Digital Medical Technology Co (SHSE:688607), the current Beneish M-Score is -2.29 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Careray Digital Medical Technology Co (SHSE:688607) Overvalued in 2026?

Based on GuruFocus' analysis, Careray Digital Medical Technology Co stock appears to be overvalued. The current stock price of ¥46.70 is trading 58.5% above its estimated GF Value™ of ¥29.46. GuruFocus considers Careray Digital Medical Technology Co to be Significantly Overvalued.

Key valuation signals for SHSE:688607:

  • Beneish M-Score: -2.29
  • GF Value™: ¥29.46 vs. price of ¥46.70 (58.5% above fair value)
  • GF Score™: 65/100 with 6 warning signs

No single metric tells the full story. See the SHSE:688607 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Careray Digital Medical Technology Co Business Description

Address No. 218 Xinghu Street, Room 501, Building A2 and B3, Bio-Nano Park, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN, 215123
Careray Digital Medical Technology Co Ltd is engaged in the development and production of digital X-ray flat panel detectors, which are widely used in medical, pet, security, and industrial imaging diagnostic products. The product portfolio includes radiography, mammography, fluoroscopy, dental products, and other accessories.
65GF Score

Get the complete analysis for SHSE:688607

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥46.70
Price
¥29.46
GF Value